Status:
COMPLETED
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
Lead Sponsor:
POZEN
Conditions:
Healthy
Eligibility:
All Genders
50+ years
Phase:
PHASE1
Brief Summary
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Eligibility Criteria
Inclusion
- Healthy male or non-pregnant female subjects greater than or equal to 50 years as well as other standard inclusion criteria for a study of this nature
Exclusion
- Standard exclusion criteria for a study of this nature
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00700687
Start Date
June 1 2008
End Date
July 1 2008
Last Update
January 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anaheim, California, United States